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To identify unknown human viruses, we analyzed se-
rum and cerebrospinal fluid samples from patients with 
unexplained paraplegia from Malawi by using viral metage-
nomics. A novel cyclovirus species was identified and sub-
sequently found in 15% and 10% of serum and cerebro-
spinal fluid samples, respectively. These data expand our 
knowledge of cyclovirus diversity and tropism.
The list of diseases caused by viral pathogens is ever changing and growing (1). Breakthroughs in the field 
of metagenomics had far-reaching effects on the identifica-
tion of emerging viral pathogens and on the recognition that 
an increasing number of diseases that were once attributed 
to unknown causes are actually caused by infectious agents 
(1). Paraplegia is an impairment of motor or sensory func-
tions of the lower extremities. Although it can be caused by 
spinal cord injury, nontraumatic paraplegia also should be 
considered, particularly in a tropical environment; tuber-
culosis and schistosomiasis may play a role, but in many 
cases, no firm diagnosis can be made (2). In this study, ce-
rebrospinal fluid (CSF) and serum samples were obtained 
from 58 patients from Malawi who had paraplegia of un-
known etiology and were studied for the presence of known 
or unknown viruses by using a metagenomics approach.
The Study
During 2010–2011, we enrolled 58 adults who sought 
care at Queen Elizabeth Central Hospital in Blantyre, Ma-
lawi, for unexplained paraplegia in this study. All proce-
dures were performed in compliance with relevant laws 
and institutional guidelines. The study was approved by 
the College of Medicine Research and Ethics Committee 
(P.99/00/92).
Serum and CSF samples obtained from 12 paraple-
gia patients were available for virus discovery studies by 
using random PCR amplification with next-generation 
sequencing with a 454 GS Junior Instrument (Roche, In-
dianapolis, IN, USA) (3,4). More than 234,000 trimmed 
reads were assembled by using de novo assembly in 
CLC Genomics Workbench 4.5.1 (CLC Bio, Aarhus, 
Denmark) and analyzed according to nucleotide and 
translated nucleotide BLAST searches (http://blast.ncbi.
nlm.nih.gov/Blast.cgi). Classification of sequences based 
on the taxonomic origin of the best-hit sequence was per-
formed by using MEGAN 4.40.4 (5), using E-value cut-
offs of 0.001 and 10−10 for BLASTn and BLASTx search-
es, respectively.
Most of the sequences were of eukaryotic or bacte-
rial origin or did not have hits to nucleotide or amino acid 
sequences in GenBank in agreement with previous viral 
metagenomic studies (6). Serum samples from all patients 
were positive for viruses from the family Anelloviridae in 
serum. Anellovirus infections are acquired during early 
childhood, when the virus establishes a chronic productive 
infection with long-lasting detectable viremia (7). Two of 
these patients were positive for anelloviruses in the CSF, 
which has been described (7). In 2 patients, hepatitis B vi-
rus sequences were detected. Hepatitis B virus infection 
occurs worldwide but is most prevalent in Southeast Asia 
and sub-Saharan Africa, with reported prevalence rates of 
3%–26% (8). CSF from 2 other patients showed evidence 
of HIV infection in CSF samples (Table). None of these 
viral infections seem to explain the paraplegia.
A cyclovirus genome was obtained by 454-sequenc-
ing from serum of patient VS5700009. Cycloviruses 
(family Circoviridae, genus Cyclovirus) have been de-
tected in human and chimpanzee feces and tissues of farm 
animals, bats, and dragonflies (9–12). They are nonenvel-
oped viruses with a single-stranded circular DNA genome 
of ≈2 kb (13). The genome contains 2 major inversely ar-
ranged open reading frames (ORFs) encoding the putative 
replication-associated protein (Rep) and capsid protein 
(Cap). A potential stem–loop structure with a conserved 
nonanucleotide motif located between the 5′-ends of these 
2 ORFs is required to initiate the replication of the viral 
genome (13).
The genome organization of human cyclovirus 
VS5700009 (GenBank accession no. KC771281) resem-
bles that of human cycloviruses TN18 and TN25 (11). 
The Rep ORF of human cyclovirus VS5700009 was in-
terrupted by a 96-bp intron with a splice donor site (GT) 
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and splice acceptor site (AG). The 3′ intergenic region 
between the Rep and Cap ORFs was only 7 bp long. 
The cyclovirus stem–loop structure with the conserved 
nonamer sequence (5′-TAATACTAT-3′) in the 5′ in-
tergenic region was observed, as were 3 other potential 
ORFs (Figure, panel A, Appendix, wwwnc.cdc.gov/EID/
article/19/9/13-0404-F1.htm). These latter ORFs are not 
conserved among cycloviruses and show low partial ho-
mology to bacterial enzymes, NAD-dependent DNA li-
gase of Psychrobacter (ORF3), transketolase of Sinorhi-
zobium (ORF4), and dTDP-D-glucose 4,6-dehydratase of 
Actinomyces (ORF5). The complete Rep protein of hu-
man cyclovirus VS5700009 and representative strains of 
cycloviruses were used for phylogenetic analysis (Figure, 
panel B, Appendix). Multiple alignments were created 
by using ClustalX (2.0.10) (14). Phylogenetic analyses 
were conducted with MEGA5 (15). The human cyclovi-
rus VS5700009 Rep protein was most closely related to 
the Rep proteins of human cycloviruses TN18 and TN25 
(≈75% aa identity) (11). Similar relations, but with much 
lower amino acid identities, were observed in Cap pro-
teins (≈37% identity; data not shown). Cycloviruses be-
long to the same species when sharing >85% aa identity in 
the Rep region (11). Thus, human cyclovirus VS5700009 
represents a new cyclovirus species. Most of the closest 
relatives of human cyclovirus VS5700009 (which include 
TN18 and TN25) detected in feces from children with 
nonpolio acute flaccid paralysis (11), a condition related 
to paraplegia, which may indicate that TN25/VS5700009-
like viruses may be more pathogenic than other cyclovi-
ruses (Figure, panel B, Appendix).
To determine the prevalence of human cyclovirus 
VS5700009 in the serum and CSF samples of the 58 pa-
tients, a VS5700009-specific PCR was performed. Total 
nucleic acid was extracted from an aliquot (≈100 µl) of 
serum and CSF samples by using the Magnapure LC total 
nucleic acid isolation kit and the MagNAPure LC isola-
tion station (Roche). A genomic area, corresponding to nt 
373–752 in human cyclovirus VS5700009, was amplified 
by nested PCR, with primers VS711 (5′-CGAGCGCA-
CATTGAGAAAG-3′) and VS712 (5′-CCATCCCAC-
CATTCTCCTC-3′) by using Amplitaq gold DNA poly-
merase (Roche). Negative water controls were taken 
along. Eight (15%) of 54 serum samples and 4 (10%) of 
40 CSF samples from paraplegia patients were human 
cyclovirus positive (Table). For several amplicons, the 
cyclovirus nature was confirmed by Sanger sequencing, 
and the amplicons showed 75%–99% identity to human 
cyclovirus VS5700009 (Figure, panel C, Appendix). Only 
in patient VS5700009 were both CSF and serum samples 
positive for human cyclovirus.
Conclusions
Our results indicate that cycloviruses are commonly 
found in serum and CSF of paraplegia patients from Ma-
lawi. Diverse cycloviruses have been discovered in human 
and chimpanzee fecal samples and in muscle tissue of farm 
animals, such as cows, sheep, goats, and chickens (11). Cy-
cloviruses have been suggested to cause human enteric in-
fections and were not derived from consumed food because 
the human and animal cycloviruses showed limited genetic 
overlap (11). Our data indicate that cycloviruses may cause 
systemic infections and are present in multiple organ com-
partments in humans. Whether cycloviruses play a role in 
development of paraplegia remains to be determined; this 
study lacks a control group of healthy persons, and the 
relatively high virus prevalence in persons with paraplegia 
may also reflect high overall prevalence in healthy persons. 
In addition, the apparent interleaved evolution of human 
and animal cycloviruses suggests the potential for frequent 
cross-species exposure and zoonotic transmission.
Our observations expand the knowledge of cyclovirus-
es in humans and show how epidemiologic baseline infor-
mation on virus host range and tropism in animals (11) may 
indicate the presence of similar viruses in different organ 
systems of humans. To clarify the epidemiology and patho-
genicity of cycloviruses in humans, additional surveillance 
should be conducted, especially because the prevalence and 
diversity of human cycloviruses is relatively high (11; this 
study), cross-species transmission of cycloviruses seems 
plausible (10), and closely related cyclovirus species may 
be pathogenic.
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Table. Viruses detected in serum and CSF samples from patients 
with paraplegia in a study of novel human cyclovirus, Malawi, 
2010–2011* 
Patient no. 
Next-generation sequence  Cyclovirus 
Serum CSF  Serum CSF 
VS5700001 Anelloviridae     
VS5700002 Anelloviridae    + 
VS5700003 Anelloviridae     
VS5700004 Anelloviridae, 
HBV 
    
VS5700005 Anelloviridae     
VS5700006 Anelloviridae HIV-1    
VS5700007 Anelloviridae     
VS5700008 Anelloviridae, 
HBV 
HIV-1, 
Anelloviridae 
   
VS5700009 Anelloviridae, 
Cyclovirus 
  + + 
VS5700010 Anelloviridae Anelloviridae  +  
VS5700011 Anelloviridae     
VS5700012 Anelloviridae     
VS5700021 NA NA  +  
VS5700022 NA NA  NA + 
VS5700025 NA NA  +  
VS5700029 NA NA  +  
VS5700031 NA NA  +  
VS5700040 NA NA  + NA 
VS5700042 NA NA  + NA 
VS5700044 NA NA   + 
*CSF, cerebrospinal fluid; +, positive; HBV, hepatitis B virus; NA, not 
available. Blank cells indicate negative results. 
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